logo
▶ About us
▶ News & Events
▶ For Physicians
▶ How you can help
▶ Site Map
Sign up for our mailing list!
 
Visit our Facebook page
 
Exercise and Thalassemia
 
New Fetal Transplant Study
 
Thalassemia Adoption Clinic
 
 
 
 
 
Sign up for our newsletter
 
Story of an Alpha Thalassemia Baby


CELEGENE BELIEVE, Phase 3

Research -- Open Studies:
▶ Fetal Transplant Study
▶ Erythroferrone Study
Research -- Closed Studies:
▶ Celgene Believe Phase 3
Research -- Other:
▶ TCRN
▶ SQUID Update
▶ DEXA Update
▶ Published articles

A Phase 3, Double-blind, Randomized, Placebo-controlled, Multicenter Study to Determine the Efficacy and Safety of Luspatercept the Study Drug Versus Placebo in Adults who Require Regular Red Blood Cell Transfusions Due to Beta-Thalassemia

November 10, 2017

UCSF Benioff Children's Hospital Oakland has completed enrollment for this study, and is no longer enrolling patients.

Study Background

This study is intended to test the safety and efficacy of a drug called Luspatercept for people with transfusion-dependent Beta-thalassemia. The investigators would like to know whether Luspatercept can increase hemoglobin levels and reduce the number of units of blood people receive during transfusions or increase the amount of time between transfusions.

This study may be a good fit for you if:

If You Decide to Participate in This Study:

Contact: Jennifer Ferguson

Updated 11/10/2017


Northern California Comprehensive Thalassemia Center
UCSF Benioff Children's Hospital Oakland
747 52nd Street, Oakland CA 94609   •   Phone: (510) 428-3651   •   Fax: (510) 450-5647
© 2003-2012 Children's Hospital & Research Center Oakland
Facebook logo Twitter logo Youtube logo Blogger logo
| Home | Our Program | Contact Us | For physicians | What is thalassemia? | Genetics | Treatment | Research | Living with thalassemia | Site Map |